查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1971513

机器人辅助内视镜市场－全球产业规模、份额、趋势、机会、预测：按最终用户、地区和竞争对手划分，2021-2031年

Robot-assisted Endoscope Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By End User (Hospitals, Outpatient Facilities, Others), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球机器人辅助内视镜市场预计将从 2025 年的 15.1 亿美元成长到 2031 年的 23.6 亿美元，复合年增长率为 7.73%。

这些电子机械设备旨在辅助医生诊断和治疗消化器官系统疾病，与传统手动器械相比，它们具有更优异的稳定性、可视性和操作性。市场成长的主要驱动因素是慢性消化系统疾病盛行率的上升以及对能够缩短住院时间的微创手术需求的不断增长。例如，美国癌症协会 (ACS) 估计，到 2024 年，美国将新增约 152,810 例结直肠癌病例，这凸显了这些技术所面临的疾病负担之重。

市场概览
预测期 2027-2031
市场规模：2025年 15.1亿美元
市场规模：2031年 23.6亿美元
复合年增长率：2026-2031年 7.73%
成长最快的细分市场 门诊部
最大的市场 北美洲

儘管成长要素强劲，但由于机器人平台的高昂购买和维修成本，市场仍面临许多障碍。这些经济障碍限制了机器人技术的普及，尤其是在小规模的医疗机构和报销机制不完善的发展中地区。此外，医护人员掌握这些复杂系统所需的学习曲线陡峭，也造成了营运瓶颈。这些经济和培训方面的限制持续阻碍机器人辅助技术在标准临床实践中的广泛应用。

市场驱动因素

人工智慧的进步和柔性机器人平台的开发正在从根本上改变全球机器人辅助内视镜市场，使医生能够进入以往难以触及的解剖结构。软体机器人和可操控导管的创新使医生能够比使用手动器械更稳定、更精确地在肺部和消化道的复杂路径中穿梭。这项技术进步证明了复杂平台的安全性，并加速了其商业化进程。 2024年12月，EndoQuest Robotics在新闻稿中宣布，美国FDA已核准其柔软性腔手术系统研究医疗设备豁免（IDE），允许其开展结直肠手术的临床试验，这标誌着该领域取得了重大进展，也证实了这些技术已接近临床应用成熟阶段。

肺部和胃肠道疾病的日益普遍正显着推动市场扩张，因为医疗服务提供者面临越来越大的压力，需要提供微创切片检查和治疗性介入。肺癌等复杂疾病发生率的上升，需要先进的诊断工具来提高早期检出率，推动了机器人辅助支气管镜检查的广泛应用。例如，美国肺臟协会 (ALA) 的《2024 年肺癌现况报告》预测，2024 年美国将新增约 23.5 万例肺癌病例。疾病数量的增加直接促进了在现有平台上进行的手术数量。因此，直觉外科公司 (Intuitive Surgical) 在 2024 年 10 月的收益报告中宣布，使用其 Ion Lumen 手术系统进行的手术数量同比增长约 73%，证实了这些技术在临床实践中的快速普及。

市场挑战

全球机器人辅助内视镜市场成长的主要障碍在于这些先进平台的高昂购买和维修成本。这一沉重的经济负担限制了市场渗透率，尤其是在利润微薄的小规模区域医院和门诊手术中心。当医疗机构面临预算限制时，它们往往优先考虑必要的营运支出，而非投资昂贵的先进技术，因为这些技术尚未建立完善的报销机制。因此，难以证明这些高成本系统的投资报酬率（ROI）直接阻碍了机器人辅助内视镜的广泛应用。

近期行业数据显示，医疗机构面临沉重的财务负担，进一步印证了上述经济压力。根据美国医院协会 (AHA) 预测，到 2024 年，医院设施、设备和资本财的平均使用寿命将延长 10% 以上。这是因为不断上涨的营运成本和不足的报销迫使医疗机构推迟购买新的医疗技术。资本支出的减少对机器人辅助内视镜市场产生了负面影响，因为医疗机构管理者被迫推迟或取消高价值电子机械设备的采购，转而优先维护现有的低成本手动器械。

市场趋势

远端手术和远端临床监测解决方案的发展正在突破地域限制，扩大专科胃肠病护理的覆盖范围。先进的机器人系统与低延迟通讯网路相结合，使专家能够远端操作内视镜，让医疗资源匮乏地区的患者无需出行即可及时接受治疗。对于需要专业技术的复杂手术而言，这项技术尤其重要，因为它能够有效地普及高品质诊断服务。例如，《医疗IT新闻》在远端医疗年9月报道，香港中文大学和苏黎世联邦理工学院的一个研究团队成功地在相距5700英里（约9200公里）的香港，透过瑞士主机远端操控磁性切片检查，对活检猪模型进行了活检，这充分展现了远距医疗的潜力。

同时，自主导航和磁力操控技术的出现正在彻底改变内视镜检查的侵入性和工作流程。与传统的手动操作器械和机械导管不同，新一代平台利用外部磁场精确引导可吞嚥胶囊或软式内视镜在商业性内移动。这显着降低了患者的不适感，通常无需镇静。这种磁力驱动、无缆线运动方式最大限度地减少了组织损伤，简化了手术操作，并使其适用于各种临床环境。例如，2024年6月，《机器人报告》报告称，Endiatx公司已获得700万美元的资金筹措，用于推进其PillBot系统的临床开发。 PillBot系统是一种可吞嚥的机器人胶囊，可由医生在胃内进行主动操控。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球机器人辅助内视镜市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依最终用户（医院、门诊等）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美机器人辅助内视镜市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲机器人辅助内视镜市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区机器人辅助内视镜市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲机器人辅助内视镜市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美机器人辅助内视镜市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球机器人辅助内视镜市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Asensus Surgical Inc
  • Intuitive Surgical Inc
  • Auris Health Inc
  • Johnson & Johnson Services, Inc.
  • Brainlab AG
  • Medtronic PLC
  • Boston Scientific Corp
  • Stryker Corp

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 21762

The Global Robot-assisted Endoscope Market is projected to expand from USD 1.51 Billion in 2025 to USD 2.36 Billion by 2031, reflecting a CAGR of 7.73%. These electromechanical devices are engineered to augment physician capabilities during gastrointestinal diagnostic and therapeutic procedures, offering superior stability, visualization, and dexterity compared to traditional manual instruments. Market growth is largely driven by the rising prevalence of chronic digestive disorders and a growing preference for minimally invasive interventions that shorten hospitalization times. Highlighting the significant disease burden necessitating such technologies, the American Cancer Society reported that approximately 152,810 new cases of colorectal cancer were estimated to be diagnosed in the United States in 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.51 Billion
Market Size 2031USD 2.36 Billion
CAGR 2026-20317.73%
Fastest Growing SegmentOutpatient Facilities
Largest MarketNorth America

Despite these strong growth drivers, the market encounters substantial obstacles due to the high capital acquisition and maintenance costs linked to robotic platforms. This financial barrier restricts adoption, particularly among smaller healthcare facilities and in developing regions where reimbursement frameworks may be inadequate. Additionally, the steep learning curve required for medical professionals to master these complex systems creates an operational bottleneck. These economic and training constraints continue to hinder the widespread integration of robot-assisted technologies into standard clinical practice.

Market Driver

Advancements in artificial intelligence and the creation of flexible robotic platforms are fundamentally transforming the Global Robot-assisted Endoscope Market by enabling access to anatomical structures that were previously unreachable. Innovations in soft robotics and steerable catheters allow physicians to navigate complex pathways within the lungs and gastrointestinal tract with greater stability and precision than manual instruments. This technical progress is validating the safety of complex platforms and accelerating their commercialization path. A significant milestone occurred in December 2024, when EndoQuest Robotics announced via press release that the U.S. FDA granted an Investigational Device Exemption (IDE) for its flexible Endoluminal Surgical System to commence trials for colorectal procedures, confirming the maturity of these technologies for clinical adoption.

The growing prevalence of pulmonary and gastrointestinal disorders significantly fuels market expansion as healthcare providers face increasing pressure to perform biopsies and therapeutic interventions with minimal trauma. The rising incidence of complex conditions, such as lung cancer, necessitates advanced diagnostic tools capable of delivering higher yield rates for early-stage detection, thereby driving the utilization of robot-assisted bronchoscopy. For instance, the American Lung Association's '2024 State of Lung Cancer' report projected approximately 235,000 new lung cancer diagnoses in the United States in 2024. This escalating disease volume directly boosts procedure counts for established platforms; consequently, Intuitive Surgical reported in its October 2024 financial results that procedure volume for the Ion endoluminal system grew by approximately 73% year-over-year, underscoring the rapid clinical integration of these technologies.

Market Challenge

The primary obstacle hindering the growth of the Global Robot-assisted Endoscope Market is the high capital acquisition and maintenance costs associated with these advanced platforms. This substantial financial burden limits market penetration, particularly within smaller community hospitals and ambulatory surgical centers operating on narrow margins. When healthcare facilities face budget constraints, they often prioritize essential operational expenses over investing in premium, high-cost technologies that lack robust reimbursement pathways. Consequently, the difficulty in justifying the return on investment for these expensive systems directly stalls the broader adoption of robot-assisted endoscopy.

This economic pressure is further evidenced by recent industry data highlighting the financial strain on healthcare providers. According to the American Hospital Association, the average age of hospital plant and capital equipment increased by over 10% in 2024 as facilities were forced to delay purchasing new medical technologies due to rising operational costs and insufficient reimbursement. This contraction in capital spending power negatively impacts the robot-assisted endoscope market, as healthcare administrators are compelled to defer or cancel the acquisition of high-value electromechanical devices in favor of maintaining existing, lower-cost manual instruments.

Market Trends

The development of telesurgery and remote clinical monitoring solutions is expanding the availability of specialized gastrointestinal care by overcoming geographical limitations. Advanced robotic systems integrated with low-latency communication networks now allow expert physicians to manipulate endoscopes from distant locations, ensuring that patients in underserved regions can receive timely interventions without the need for travel. This capability is particularly vital for complex procedures where the requisite technical expertise is concentrated in major medical centers, effectively democratizing access to high-quality diagnostics. Validating this remote potential, Healthcare IT News reported in September 2024 that researchers from the Chinese University of Hong Kong and ETH Zurich successfully conducted a biopsy on a live porcine model over a distance of 5,700 miles, controlling a magnetic endoscope in Hong Kong from a console in Switzerland.

Simultaneously, the emergence of autonomous navigation and magnetic steering capabilities is revolutionizing the invasiveness and workflow of endoscopic examinations. Unlike traditional manually pushed instruments or mechanically actuated catheters, these next-generation platforms utilize external magnetic fields to precisely guide ingestible capsules or soft scopes through the digestive tract, significantly reducing patient discomfort and often eliminating the need for sedation. This shift toward magnetically driven, tether-free mobility minimizes tissue trauma and streamlines the procedural footprint, facilitating use in diverse clinical settings. Highlighting the commercial momentum of this technology, The Robot Report noted in June 2024 that Endiatx secured $7 million in funding to advance the clinical development of its PillBot system, a swallowable robotic capsule that physicians can actively steer inside the stomach.

Key Market Players

  • Asensus Surgical Inc
  • Intuitive Surgical Inc
  • Auris Health Inc
  • Johnson & Johnson Services, Inc.
  • Brainlab AG
  • Medtronic PLC
  • Boston Scientific Corp
  • Stryker Corp

Report Scope

In this report, the Global Robot-assisted Endoscope Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Robot-assisted Endoscope Market, By End User

  • Hospitals
  • Outpatient Facilities
  • Others

Robot-assisted Endoscope Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Robot-assisted Endoscope Market.

Available Customizations:

Global Robot-assisted Endoscope Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Robot-assisted Endoscope Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By End User (Hospitals, Outpatient Facilities, Others)
    • 5.2.2. By Region
    • 5.2.3. By Company (2025)
  • 5.3. Market Map

6. North America Robot-assisted Endoscope Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By End User
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Robot-assisted Endoscope Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By End User
    • 6.3.2. Canada Robot-assisted Endoscope Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By End User
    • 6.3.3. Mexico Robot-assisted Endoscope Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By End User

7. Europe Robot-assisted Endoscope Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By End User
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Robot-assisted Endoscope Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By End User
    • 7.3.2. France Robot-assisted Endoscope Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By End User
    • 7.3.3. United Kingdom Robot-assisted Endoscope Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By End User
    • 7.3.4. Italy Robot-assisted Endoscope Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By End User
    • 7.3.5. Spain Robot-assisted Endoscope Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By End User

8. Asia Pacific Robot-assisted Endoscope Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By End User
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Robot-assisted Endoscope Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By End User
    • 8.3.2. India Robot-assisted Endoscope Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By End User
    • 8.3.3. Japan Robot-assisted Endoscope Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By End User
    • 8.3.4. South Korea Robot-assisted Endoscope Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By End User
    • 8.3.5. Australia Robot-assisted Endoscope Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By End User

9. Middle East & Africa Robot-assisted Endoscope Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By End User
    • 9.2.2. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Robot-assisted Endoscope Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By End User
    • 9.3.2. UAE Robot-assisted Endoscope Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By End User
    • 9.3.3. South Africa Robot-assisted Endoscope Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By End User

10. South America Robot-assisted Endoscope Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By End User
    • 10.2.2. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Robot-assisted Endoscope Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By End User
    • 10.3.2. Colombia Robot-assisted Endoscope Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By End User
    • 10.3.3. Argentina Robot-assisted Endoscope Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Robot-assisted Endoscope Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Asensus Surgical Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Intuitive Surgical Inc
  • 15.3. Auris Health Inc
  • 15.4. Johnson & Johnson Services, Inc.
  • 15.5. Brainlab AG
  • 15.6. Medtronic PLC
  • 15.7. Boston Scientific Corp
  • 15.8. Stryker Corp

16. Strategic Recommendations

17. About Us & Disclaimer